Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:1653-1657
Published online before print March 17, 2003, doi: 10.1161/01.CIR.0000058170.92267.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/12/1653    most recent
01.CIR.0000058170.92267.00v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torsney, E.
Right arrow Articles by Arthur, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torsney, E.
Right arrow Articles by Arthur, H. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Angiogenesis
Right arrow Animal models of human disease
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2003;107:1653.)
© 2003 American Heart Association, Inc.


Basic Science Reports

Mouse Model for Hereditary Hemorrhagic Telangiectasia Has a Generalized Vascular Abnormality

Evelyn Torsney, PhD; Richard Charlton, PhD; Austin G. Diamond, PhD; John Burn, MD; James V. Soames, PhD; Helen M. Arthur, PhD

From the Institute of Human Genetics, International Centre for Life (E.T., J.B., H.M.A.), Microbiology and Immunology (A.G.D.), and Oral Pathology, University of Newcastle upon Tyne (J.V.S.); and Histopathology, Freeman Hospital (R.C.), Newcastle upon Tyne, UK.

Correspondence to Dr Helen M. Arthur, Institute of Human Genetics, International Centre for Life, University of Newcastle upon Tyne, NE1 3BZ, UK. E-mail helen.arthur{at}ncl.ac.uk

Background— Mutations in endoglin or activin like kinase-1, both involved in the endothelial transforming growth factor-ß signaling pathway, cause the autosomal dominant bleeding disorder hereditary hemorrhagic telangiectasia. We and others have reported mouse models for this disease that share the characteristic phenotype of dilated vessels and sporadic hemorrhage. The reasons for the variable phenotype in hereditary hemorrhagic telangiectasia are not understood.

Methods and Results— After a detailed immunohistochemical analysis of 129/Ola mice, which are heterozygous for a targeted deletion in the endoglin gene, we observed intrinsic abnormalities in the vascular walls throughout the cutaneous vasculature. Postcapillary venules were dilated, and up to 70% of the vascular wall had no smooth muscle cells. The supporting layers of collagens and elastin were irregular, with thin areas, adding to the fragility of these vessels. A variable hemorrhagic phenotype was observed in which local bleeding is associated not only with fragile vessels but also with regions of inflammation.

Conclusions— These findings have relevance to our understanding of the molecular basis of vascular integrity in a wide range of diseases.


Key Words: vasculature • angiogenesis • hemorrhage • inflammation




This article has been cited by other articles:


Home page
BloodHome page
S. O. Park, Y. J. Lee, T. Seki, K.-H. Hong, N. Fliess, Z. Jiang, A. Park, X. Wu, V. Kaartinen, B. L. Roman, et al.
ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2
Blood, January 15, 2008; 111(2): 633 - 642.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Liu, J. Wang, B. Kinzel, M. Mueller, X. Mao, R. Valdez, Y. Liu, and E. Li
Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity
Blood, September 1, 2007; 110(5): 1502 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
A. Fernandez-L, F. Sanz-Rodriguez, F. J. Blanco, C. Bernabeu, and L. M. Botella
Hereditary Hemorrhagic Telangiectasia, a Vascular Dysplasia Affecting the TGF-{beta} Signaling Pathway.
Clin. Med. Res., March 1, 2006; 4(1): 66 - 78.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Armulik, A. Abramsson, and C. Betsholtz
Endothelial/Pericyte Interactions
Circ. Res., September 16, 2005; 97(6): 512 - 523.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Lebrin, M. Deckers, P. Bertolino, and P. ten Dijke
TGF-{beta} receptor function in the endothelium
Cardiovasc Res, February 15, 2005; 65(3): 599 - 608.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. L. C. Carvalho, L. Jonker, M.-J. Goumans, J. Larsson, P. Bouwman, S. Karlsson, P. t. Dijke, H. M. Arthur, and C. L. Mummery
Defective paracrine signalling by TGF{beta} in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia
Development, December 15, 2004; 131(24): 6237 - 6247.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
A Karabegovic, M Shinawi, U Cymerman, and M Letarte
No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia
J. Med. Genet., November 1, 2004; 41(11): e119 - e119.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J.-C. Tille and M.S. Pepper
Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1578 - 1590.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Seki, J. Yun, and S. P. Oh
Arterial Endothelium-Specific Activin Receptor-Like Kinase 1 Expression Suggests Its Role in Arterialization and Vascular Remodeling
Circ. Res., October 3, 2003; 93(7): 682 - 689.
[Abstract] [Full Text] [PDF]